about
Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integ...
Read More
69.90
0.60
(0.87%)
16,420.7
XNAS Volume
XNAS 13 Mar, 2026 10:49 AM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Inhibrx Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..